Literature DB >> 26718396

Polymicrobial soft tissue infection including Shewanella putrefaciens.

M Mohr1, J Köstler2, B Salzberger3, F Hanses4,5.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26718396     DOI： 10.1007/s15010-015-0868-5

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  5 in total

1.  CAPD, swimming in Shewanella.

Authors:  S Bhandari; T L Pan; J Horvath; D Tiller
Journal:  Nephrol Dial Transplant       Date:  2000-09       Impact factor: 5.992

2.  Soft tissue infection and bacteremia caused by Shewanella putrefaciens.

Authors:  Leonardo Pagani; Adolf Lang; Claudio Vedovelli; Oswald Moling; Giovanni Rimenti; Raffaele Pristerà; Peter Mian
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

Review 3.  Shewanella algae and Shewanella putrefaciens: clinical and microbiological characteristics.

Authors:  H M Holt; B Gahrn-Hansen; B Bruun
Journal:  Clin Microbiol Infect       Date:  2005-05       Impact factor: 8.067

Review 4.  Skin and soft-tissue manifestations of Shewanella putrefaciens infection.

Authors:  Y S Chen; Y C Liu; M Y Yen; J H Wang; J H Wang; S R Wann; D L Cheng
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

5.  Concurrent infection due to Shewanella putrefaciens and Mycobacterium marinum acquired at the beach.

Authors:  K Papanaoum; G Marshmann; L A Gordon; R Lumb; D L Gordon
Journal:  Australas J Dermatol       Date:  1998-05       Impact factor: 2.875
  5 in total
  2 in total

1.  Shewanella spp. infections in Gran Canaria, Spain: retrospective analysis of 31 cases and a literature review.

Authors:  Alberto J Martín-Rodríguez; Oriol Martín-Pujol; Fernando Artiles-Campelo; Margarita Bolaños-Rivero; Ute Römling
Journal:  JMM Case Rep       Date:  2017-12-07

Review 2.  Shewanella infection in humans: Epidemiology, clinical features and pathogenicity.

Authors:  Keyi Yu; Zhenzhou Huang; Yue Xiao; Duochun Wang
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.